Approval · Notice of Compliance 10073 · 2009
OXYCONTIN: Notice of Compliance 10073
Issued March 4, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10073
- Date
- March 4, 2009
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New intermediate strengths: 15 mg, 30 mg, 60 mg, 120 mg
- Therapeutic class
- Opioid analgesic
Products in this notice
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 30 MG per TAB
- OXYCODONE HYDROCHLORIDE 60 MG per TAB
- OXYCODONE HYDROCHLORIDE 120 MG per TAB
- OXYCODONE HYDROCHLORIDE 15 MG per TAB